Newsroom
Sorted by: Latest
-
MUNDYS RENFORCE SA POSITION STRATÉGIQUE AU CAPITAL DE GETLINK
ROME--(BUSINESS WIRE)--Regulatory News: Mundys annonce aujourd’hui le renforcement de sa position stratégique au capital de Getlink avec l’acquisition1 d’une participation pouvant atteindre un maximum de 9,5 % du capital de Getlink. Une première tranche représentant 3,5 % du capital de Getlink sera acquise immédiatement, Mundys disposant de la faculté d’acquérir jusqu’à 6,0 % supplémentaires sous réserve de l’obtention de l’autorisation réglementaire requise, attendue d’ici avril 20262. À l’iss...
-
Mundys Strengthens Its Strategic Position in Getlink
ROME--(BUSINESS WIRE)--Regulatory News: Mundys today announces that it strengthens its strategic position in Getlink with the acquisition1 of up to 9.5% of Getlink share capital. 3.5% of Getlink’s share capital will be acquired upfront, with the ability for Mundys to acquire up to an additional 6.0% conditional upon Mundys receiving the required regulatory approval, expected by April 20262. As a result of acquiring 3.5% of Getlink’s shares, Mundys will hold 19.0% of Getlink’s share capital and...
-
MUNDYS RAFFORZA LA PROPRIA POSIZIONE STRATEGICA IN GETLINK
ROMA--(BUSINESS WIRE)--Mundys annuncia oggi il rafforzamento della propria posizione strategica in Getlink attraverso l’acquisizione1 di una partecipazione fino al 9,5% del capitale sociale di Getlink. Una prima tranche, pari al 3,5% del capitale sociale di Getlink, sarà acquisita immediatamente; Mundys disporrà inoltre della facoltà di acquisire fino a un ulteriore 6,0%, subordinatamente all’ottenimento della autorizzazione regolamentare richiesta, attesa entro aprile 20262. A seguito dell’acq...
-
百奧賽圖與大正製藥達成RenNano®全人源僅重鏈抗體發現平台授權協議
中國北京和日本東京--(BUSINESS WIRE)--(美國商業資訊)-- (美國商業資訊)-- 百奧賽圖(北京)醫藥科技股份有限公司(以下簡稱「百奧賽圖」,SSE: 688796;HKEX: 02315)是一家以創新技術驅動新藥研發的國際性生物技術公司,該公司今日宣布與大正製藥株式會社(以下簡稱「大正製藥」)達成一項平台授權協議。百奧賽圖授予大正製藥其專有的®全人源僅重鏈抗體(HCAb)發現平台的使用權,以支援大正製藥的內部新藥研發計畫。 根據協議條款,大正製藥將利用RenNano® 全人源奈米抗體小鼠在體內(in vivo )產生並篩選全人源僅重鏈抗體,進一步推進相關的下游發現與研究工作。該協議的具體財務條款尚未披露。 百奧賽圖董事長暨執行長沈月雷博士表示:「我們非常榮幸能與大正製藥達成此次合作。RenNano®作為一款功能強大的全人源奈米抗體發現平台,能夠為多種下一代創新療法的開發提供理想的抗體分子基礎。該平台將深度賦能大正製藥的內部研發,助力其打造更為高效的全人奈米抗體發現流程。」 此次合作標誌著百奧賽圖全球合作夥伴網路的進一步拓展。得益於優異的體內免疫反應機制,RenNan...
-
MaaT Pharma Announces 2025 Annual Results and Provides Business Updates
LYON, France--(BUSINESS WIRE)--MaaT Pharma Announces 2025 Annual Results and Provides Business Updates...
-
MaaT Pharma annonce ses résultats annuels pour l’année 2025 et réalise un point sur ses activités
LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT – la “Société”), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem Therapies™ (MET) visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, annonce aujourd'hui la publication de ses résultats financiers annuels pour l’année 2025 et réalise un point sur ses activités. « 2025 a été une année de forte dynamique clini...
-
Lenovo Announces Global Partnership With David Beckham
MORRISVILLE, N.C.--(BUSINESS WIRE)--Lenovo today announced a global partnership with David Beckham, bringing together one of the world’s most recognized cultural figures and one of the world’s leading technology companies. The collaboration builds on Lenovo’s expanding role in global football, including its position as the Official Technology Partner of FIFA World Cup 2026™ and the FIFA Women’s World Cup 2027™. This first of its kind Lenovo partnership will see David Beckham participating in Le...
-
CTP Announces the Successful Signing of a Dual Tranche JP¥ 22.5 Billion and USD 180 Million Unsecured Syndicated Sustainability-Linked Asian Loan
AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP, Europe’s largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), announces the successful signing of its dual tranche Asian syndicated term loan facility (the “Asian Loan”) of JP¥ 22.5 billion (EUR 122.5 million equivalent) and USD 180 million. Proceeds will be used to contribute towards the funding of CTP’s highly profitable development pipeline. The Asian Loan is a sustainability linked...
-
Rakuten Mobile Extends Partnership with Netcracker for AI-Enabled Digital BSS to Support its Mobile Network in Japan
WALTHAM, Mass.--(BUSINESS WIRE)--Rakuten Mobile extends partnership with Netcracker for the next-generation, cloud-ready and AI-enabled Digital BSS to support all customers in Japan....
-
e.l.f. Cosmetics Cracks the Case on Vanity Vandals, the Latest Addition in its Cosmetic Crime Series
OAKLAND, Calif.--(BUSINESS WIRE)--We have a new case of makeup mayhem on our hands – who the e.l.f. is responsible this time? e.l.f. Cosmetics, a brand from e.l.f. Beauty (NYSE: ELF), the bold disruptor with a kind heart, releases today, Vanity Vandals, a true crime-inspired mockumentary that explores an e.l.f.ing epidemic taking over households everywhere. “Vanity vandalism”, as defined by e.l.f., is the act of overtaking vanities everywhere, often caused by irresistibly affordable beauty that...